Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott R Berry

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Just say dieScott R Berry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2021
Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot?Christopher M Booth, Scott R Berry
BMC Health Services Research|November 29, 2007
The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative studyScott R Berry, Stacey Hubay, Hagit Soibelman, et al.
Journal of Oncology Practice|July 2, 2013
Ethical challenges: managing oncology drug shortagesJohn Valgus, Eric A Singer, Scott R Berry, et al.
JAMA Oncology|June 9, 2017
Association Between Prognosis and Tumor Laterality in Early-Stage Colon CancerSafiya Karim, Kelly Brennan, Sulaiman Nanji, et al.
Journal of Oncology Practice|May 2, 2012
Variation and consternation: access to unfunded cancer drugs in CanadaScott R Berry, William K Evans, Elizabeth L Strevel, et al.
JAMA Oncology|April 28, 2022
Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug ClassJoseph N Samuel, Christopher M Booth, Elizabeth Eisenhauer, et al.
European Journal of Clinical Pharmacology|August 27, 2016
High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetateRehana Jamani, Esther K Lee, Scott R Berry, et al.
Journal of Oncology Practice|September 4, 2012
Less than ideal: how oncologists practice with limited drug accessKelvin K Chan, Bertha Wong, Lillian L Siu, et al.
Journal of Oncology Practice|August 15, 2013
Overcoming obstacles in accessing unfunded oral chemotherapy: physician experience and challengesDolly Han, Martina Trinkaus, Sophie Hogeveen, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Just say dieScott R Berry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2021
Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot?Christopher M Booth, Scott R Berry
BMC Health Services Research|November 29, 2007
The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative studyScott R Berry, Stacey Hubay, Hagit Soibelman, et al.
Journal of Oncology Practice|July 2, 2013
Ethical challenges: managing oncology drug shortagesJohn Valgus, Eric A Singer, Scott R Berry, et al.
JAMA Oncology|June 9, 2017
Association Between Prognosis and Tumor Laterality in Early-Stage Colon CancerSafiya Karim, Kelly Brennan, Sulaiman Nanji, et al.
Journal of Oncology Practice|May 2, 2012
Variation and consternation: access to unfunded cancer drugs in CanadaScott R Berry, William K Evans, Elizabeth L Strevel, et al.
JAMA Oncology|April 28, 2022
Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug ClassJoseph N Samuel, Christopher M Booth, Elizabeth Eisenhauer, et al.
European Journal of Clinical Pharmacology|August 27, 2016
High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetateRehana Jamani, Esther K Lee, Scott R Berry, et al.
Journal of Oncology Practice|September 4, 2012
Less than ideal: how oncologists practice with limited drug accessKelvin K Chan, Bertha Wong, Lillian L Siu, et al.
Journal of Oncology Practice|August 15, 2013
Overcoming obstacles in accessing unfunded oral chemotherapy: physician experience and challengesDolly Han, Martina Trinkaus, Sophie Hogeveen, et al.
Pageof 3